This session will be a combination of both clinical and basic science research that focuses on identifying either new treatments or therapeutic targets in the management of GI and hepatic manifestations of cystic fibrosis.
Identify a potential new treatment target in CF-associated constipation.
Discuss the use of organoids and '-omics' to better understand the impact of CFTR dysfunction on the intestinal environment.
Review the utility of imaging modalities to access GI and Hepatic disease in patients with CF.
Note: Speakers Christabella Ng and Michael Coffey's presentations were not recorded at their request.